DaVita
DVA
#1736
Rank
S$15.78 B
Marketcap
S$247.36
Share price
1.55%
Change (1 day)
48.86%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$14.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$14.04. In 2025 the company made an earnings per share (EPS) of S$12.91 a decrease over its 2024 EPS that were of S$14.07.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$14.109.22%
2025S$12.91-8.25%
2024S$14.0744.94%
2023S$9.7127.26%
2022S$7.63-35.56%
2021S$11.8444.1%
2020S$8.2219.7%
2019S$6.86540.48%
2018S$1.07-76.07%
2017S$4.48-19.31%
2016S$5.55242.52%
2015S$1.62-62.87%
2014S$4.3613.43%
2013S$3.858.45%
2012S$3.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$31.02 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$14.49 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$24.74 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.64-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA